Dr. Castro is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
13400 E Shea Blvd
Scottsdale, AZ 85259Phone+1 480-301-8000
Education & Training
- University of California (San Diego) Medical CenterFellowship, Hematology and Medical Oncology, 2000 - 2003
- University of Pennsylvania Health SystemResidency, Internal Medicine, 1997 - 2000
- Industrial University of Santander Faculty of MedicineClass of 1992, MD
- Colegio La SalleB.Sc., 1979 - 1984
Certifications & Licensure
- AZ State Medical License 2018 - 2026
- CA State Medical License 2000 - 2026
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Research Award Gateway Foundation, 2008
- Investigator Award CLL Global Research foundation, 2005
- Join now to see all
Clinical Trials
- Xcellerated T CellsTM for Non-Hodgkin's Lymphoma (NHL) Patients Start of enrollment: 2004 Mar 01
- Phase 1/2, Open-label, Dose-escalation Study of IONIS-STAT3Rx, Administered to Patients With Advanced Cancers Start of enrollment: 2012 Feb 27
Publications & Presentations
PubMed
- 108 citationsAcute lymphoblastic leukemia, version 2.2021Patrick A. Brown, Bijal D. Shah, Anjali S. Advani, Patricia Aoun, Michael Boyer
Journal of the National Comprehensive Cancer Network. 2021-09-01 - 3398 citationsAxicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell LymphomaSattva S. Neelapu, Frederick L. Locke, Nancy L. Bartlett, Lazaros J. Lekakis, David B. Miklos
The New England Journal of Medicine. 2017-12-10 - 68 citationsTargeting the spliceosome in chronic lymphocytic leukemia with the macrolides FD-895 and pladienolide-BManoj Kumar Kashyap, Deepak Kumar, Reymundo Villa, James J. La Clair, Christopher Benner
Haematologica. 2015-07-01
Journal Articles
- Phase ½ study of lumiliximab combined with fludarabine, cyclophosphamide, and rituximab in patients with relapsed or refractory chronic lymphocytic leukemiaByrd JC, Kipps TJ, Flinn IW, Castro JE, Lin TS, Wierda W, Heerema N, Woodworth J, Hughes S, Tangri S, Harris S, Wynne D, Molina A, Leigh B, O'Brien S, Blood, 1/1/2010
- Development of allogeneic hematopoietic stem cell transplantation (HSCT) (Chapter Review)Castro JE, Ball ED, Cancer Treat Res, 1/1/2002
- Nesidioblastosis: Report of the fist adult cases in ColombiaCastro JE, Delgado JC, Landazabal G, Rev Col Cirugia, 1/1/1994
- Join now to see all
Books/Book Chapters
Lectures
- A Phase Ib/II Study of Ibrutinib in Combination with Obinutuzumab-Gazyva As First-Line Treatment for Patients with Chronic Lymphocytic Leukemia > 65 Years Old or with ...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Ibrutinib Reduces Obinutuzumab-Gazyva Infusion Related Reactions (IRR) in Patients with Chronic Lymphocytic Leukemia (CLL) and It Is Associated with Changes on Plasma ...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Ibrutinib Reduces Obinutuzumab-Gazyva Infusion Related Reactions (IRR) in Patients with Chronic Lymphocytic Leukemia (CLL) and It Is Associated with Changes on Plasma ...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Other
- Clinical Review various topics in Hematology and Oncology.Castro JE, PDxMED - Online Medical Review, Elsevier Science
http://www.firstconsult.com
London, UK - 1/1/2004
Press Mentions
- Behind the Scenes–Mayo Clinic ResearchSeptember 12th, 2019
Grant Support
- Clinical Trial: Adenovirus Cd-154 In Subjects With CLLNational Center For Research Resources2010
- Clinical Trial: A Phase II Study Of Repeat Intranodal Injections Of Adenovirus-CNational Center For Research Resources2010
- Phase I, Open-Label Dose-EscalationFood And Drug Administration2008–2010
- Clinical Trial: PK Study Of Intranodal Injection Of Adenovirus-Cd154 In PatientsNational Center For Research Resources2008–2009
- Immunotherapy For Chronic Lymphocytic LeukemiaNational Cancer Institute2004–2008
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: